Two years of experience in the treatment of status epilepticus with intravenous levetiracetam

Epilepsy and Behavior

Volumn 15, Issue 4, 2009, Pages 467-469

  Eue, S ^a   Grumbt, M ^a   Muller M ^a   Schulze, A ^a  

^a Klinikum Bernburg gGmbH   (Germany)

Author keywords

Compatibility; Intravenous; Levetiracetam; Status epilepticus; Therapeutic effect

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; ETIRACETAM; LORAZEPAM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EPILEPTIC STATE; FEMALE; HUMAN; MALE; METABOLIC DISORDER; SOMNOLENCE; TREATMENT DURATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CEREBROVASCULAR DISORDERS; EPILEPSIES, MYOCLONIC; EPILEPSIES, PARTIAL; FEMALE; GERMANY; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PIRACETAM; STATUS EPILEPTICUS;

EID: 67849084811     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2009.05.020     Document Type: Article

References (24)

1. Chin R.F., Neville B.G., Peckham C., Bedford H., Wade A., and Scott R.C. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 368 (2006) 222-229
2. DeLorenzo R.J., Hauser W.A., Towne A.R., et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46 (1996) 1029-1035
3. Koubeissi M., and Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus. Neurology 69 (2007) 886-893
4. Logroscino G., Hesdorffer D.C., Cascino G., Annegers J.F., and Hauser W.A. Short-term mortality after a first episode of status epilepticus. Epilepsia 38 (1997) 1344-1349
5. Towne A.R., Pellock J.M., Ko D., and DeLorenzo R.J. Determinants of mortality in status epilepticus. Epilepsia 35 (1994) 27-34
6. Vignatelli L., Tonon C., and D́Alessandro R. Incidence and short-term prognosis of status epilepticus in adults in Bologna. Epilepsia 44 (2003) 964-968
7. Wu Y.W., Shek D.W., Garcia P.A., Zhao S., and Johnston S.C. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 58 (2002) 1070-1076
8. Altenmüller D.M., Kühn A., Surges R., and Schulze-Bonhage A. Termination of absence status epilepticus by low dose intravenous levetiracetam. Epilepsia 49 (2008) 1289-1290
9. Farooq M.U., Naravetla B., Majid A., Gupta R., Pysh J.J., and Kassab M.Y. IV levetiracetam in the management of non-convulsive status epilepticus. Neurocrit Care 7 (2007) 36-39
10. Rupprecht S., Franke K., Fitzek S., Witte O.W., and Hagemann G. Levetiracetam as a treatment option in nonconvulsive status epilepticus. Epilepsy Res 73 (2007) 238-244
11. Trabacca A., Profice P., Costanza M.C., Gesualdi M., and DeRinaldis M. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report. J Child Neurol 22 (2007) 639-641
12. Lowenstein D.H., Black T., and Macdonald R.L. It́s time to revise the definition of status epilepticus. Epilepsia 40 (1999) 120-122
13. Nandhagopal R. Generalized convulsive status epilepticus: an overview. Postgrad Med J 82 (2006) 723-732
14. Milikan D., Rice B., and Silbergleit R. Emergency treatment of status epilepticus: current thinking. Emerg Med Clin North Am 27 (2009) 101-113
15. Ramael S., Daoust A., Otoul C., et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 47 (2006) 1128-1135
16. Feddersen B, Einhellig M, Vollmar C, Ricken J, Mauerer C, Noachtar S. The role of levetiracetam in treatment of status epilepticus: review of 68 patients. Poster presented at 1st London Colloquium on Status Epilepticus. London; April 12-14, 2007.
17. Knake S., Gruener J., Hattemer J., et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry 79 (2008) 588-589
18. Doheny H.C., Ratnaraj N., Whittington M.A., Jefferys J.G., and Patsalos P.N. Blood and cerebrospinal fluid pharmacokinetics of the novel anticonvulsant levetiracetam (UCB L059) in the rat. Epilepsy Res 34 (1999) 161-168
19. Tong X., and Patsalos P.N. A microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brain. Br J Pharmacol 133 (2002) 867-874
20. Ji-qun C., Ishihara K., Nagayama T., Serikawa T., and Sasa M. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs. Epilepsia 46 (2005) 1362-1370
21. Gibbs J.E., Walker M.C., and Cock H.R. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia 47 (2006) 469-478
22. Broesener G, Dobesberger J, Seppi K et al. Intravenous levetiracetam in seizure emergency situations including status epilepticus. Poster presented at 1st London Colloquium on Status Epilepticus. London; April 12-14, 2007.
23. Eckert M., and Besser R. Rapid intravenous infusion of levetiracetam: tolerability and pharmacokinetics in elderly epileptic patients. Akt Neurol 35 (2008) 211-213
24. Rüegg S., Naegelin Y., Hardmeier M., Winkler D.T., Marsch S., and Fuhr P. Intravenous levetiracetam: treatment experience with the first 50 critically ill patients. Epilepsy Behav 12 (2008) 477-480